Metabolic Syndrome and Prostate Cancer: A Review

Abstract Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development of metabolic syndrome and cardiovascular disease as a consequence of this therapy, and highlight s...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Clinical oncology (Royal College of Radiologists (Great Britain)) 2009-04, Vol.21 (3), p.183-191
Hauptverfasser:	Nobes, J.P, Langley, S.E.M, Laing, R.W
Format:	Artikel
Sprache:	eng
Schlagworte:	Androgen Antagonists - adverse effects Androgen Antagonists - therapeutic use Androgen deprivation therapy Gonadotropin-Releasing Hormone - agonists Hematology, Oncology and Palliative Medicine Humans insulin resistance Male metabolic syndrome Metabolic Syndrome - etiology Orchiectomy - adverse effects prostate cancer Prostatic Neoplasms - metabolism Prostatic Neoplasms - therapy Radiology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Abstract Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development of metabolic syndrome and cardiovascular disease as a consequence of this therapy, and highlight strategies aimed at their prevention. The relationship between metabolic syndrome and prostate cancer development will also be examined.
ISSN:	0936-6555 1433-2981
DOI:	10.1016/j.clon.2008.11.013